Product NewsCorgenix Files Concurrent de novo 510(k) Pre-Market Notification for FDA Clearance of its Hyaluronic Acid (HA) Test Kit
Product NewsCorgenix Announces Initial Phase Completion of Multi-Year Pivotal Clinical Trial of Rapid Test for Lassa Fever